Physician profile
Barbara J Gans
NPI 1003864000
$254.57
in general payments reported to CMS, 2019-2025
10 companies · $71.38 in 2025
The $71.38 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.09 · 2020: $14.71 · 2021: $18.25 · 2022: $28.97 · 2023: $25.11 · 2024: $15.06 · 2025: $71.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $52.03 | 2019-2025 | Doc Band |
| Tris Pharma INC | $40.86 | 2021-2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $29.09 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $28.53 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $25.11 | 2023 | |
| Collegium Pharmaceutical, INC. | $18.72 | 2025 | Jornay Pm |
| Kaleo, INC. | $17.54 | 2019 | |
| Mylan Pharmaceuticals INC. | $17.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.44 | 2019 | |
| Galderma Laboratories, L.P. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Gans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.